rs1064793228
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000444.6(PHEX):c.1482+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000444.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1027335Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 305803
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 418407). Disruption of this splice site has been observed in individual(s) with hypophosphatemic rickets (PMID: 9768674, 11502829, 23079138; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 13 of the PHEX gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PHEX are known to be pathogenic (PMID: 9097956, 9106524, 19219621). -
To our knowledge, the c.1482+1 G>A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant. The c.1482+1 G>A splice site variant in the PHEX gene destroys the canonical splice donor site in intron 13 and is predicted to cause abnormal gene splicing. This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Additionally, splice variants at the same nucleotide position (c.1482+1 G>T and c.1482+1 G>C) have been reported in patients with hypophosphatemic rickets (Durmaz et al., 2013; Dixon et al., 1998; Holm et al., 2001). Furthermore, other splice variants in intron 13 have been reported in the Human Gene Mutation Database in association with hypophosphatemic rickets (Stenson et al., 2014). In summary, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
- -
Familial X-linked hypophosphatemic vitamin D refractory rickets Pathogenic:1
The variant is not observed in the gnomAD v2.1.1 dataset. Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000418407). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at